Qubit Pharmaceuticals

Paris, France · Founded 2020 · Privately Held (backing)

Developer of a drug discovery simulation platform designed to reduce the cost and length of preclinical drug development. Qubit Pharmaceuticals is based in Paris, France and was founded in 2020. Its last reported valuation was $48.1 million in Jun 2022. It has raised $28.7 million.

Last reported valuation
$48.1M
Oct 2026
Priced at
—
Total raised
$28.7M
Last round
—

Who backs Qubit Pharmaceuticals?

11 investors
InvestorType
European Innovation CouncilVenture capital
La French TechOther
XAngeVenture capital
Omnes CapitalPE / buyout
Audacia—
EIT Health—
European Innovation Council (Belgium)—
French Tech Health20 Program—
Octave Klaba—
Paris Biotech Sante—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Qubit Pharmaceuticals investors

11 investors are on record for Qubit Pharmaceuticals, including European Innovation Council, La French Tech, XAnge and Omnes Capital.

Free account
More of Qubit Pharmaceuticals with a free account
  • ·The complete investor list: 11 names
  • ·Watch Qubit Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Qubit Pharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View